S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
NASDAQ:RYTM

Rhythm Pharmaceuticals SEC Filings & 10K Form

$8.62
-0.33 (-3.69%)
(As of 12/1/2021 03:59 PM ET)
Add
Compare
Today's Range
$8.58
$9.28
50-Day Range
$8.85
$13.90
52-Week Range
$8.50
$43.26
Volume
13,390 shs
Average Volume
371,396 shs
Market Capitalization
$433.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.26

Rhythm Pharmaceuticals (NASDAQ:RYTM) SEC Filings

DateFilerForm TypeView
09/15/2021
5:51 PM
Manning Linda Shapiro (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
5:49 PM
Manning Linda Shapiro (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/03/2021
6:05 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2021
7:12 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2021
7:09 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/16/2021
3:16 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4/A
06/14/2021
3:04 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
4:39 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:06 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:06 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:06 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:06 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:06 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:05 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
7:54 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2021
7:36 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2021
3:45 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
5:08 AM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
3:49 PM
Rhythm Pharmaceuticals (Issuer)
Roberts William T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
3:47 PM
Rhythm Pharmaceuticals (Issuer)
Roberts William T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/16/2021
4:13 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
10:04 AM
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
03/01/2021
3:24 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/01/2021
11:33 AM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2021
8:01 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
4:29 PM
Chien Jennifer (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
4:04 PM
BAKER BROS. ADVISORS LP (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/16/2021
3:39 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2021
2:20 PM
Rhythm Pharmaceuticals (Subject)
Form SC 13G
02/12/2021
11:31 AM
Flynn James E (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2021
11:02 AM
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2021
4:11 PM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2021
4:27 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
4:26 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
02/04/2021
9:14 AM
Rhythm Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/03/2021
4:12 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
02/03/2021
3:42 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
3:49 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:32 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K/A
12/11/2020
3:11 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:11 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:10 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2020
3:10 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2020
3:01 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2020
3:30 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
10:35 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
8:32 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
3:10 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:05 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/01/2020
3:05 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
2:16 PM
Rhythm Pharmaceuticals (Filer)
Form CT ORDER
08/13/2020
3:05 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2020
8:53 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2020
4:16 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
4:16 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
4:15 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:35 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
5:31 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
2:27 PM
MPM BIOVENTURES V, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
06/25/2020
4:38 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:28 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:08 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
5:39 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
4:14 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:48 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:59 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:28 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
10:58 AM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
05/04/2020
7:51 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEFA14A
04/29/2020
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEF 14A
04/24/2020
2:39 PM
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
04/01/2020
3:20 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
5:00 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
3:58 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:51 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
3:48 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/02/2020
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2020
3:24 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:24 PM
Kelner Simon (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:23 PM
Rhythm Pharmaceuticals (Issuer)
Stewart Murray (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:23 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
3:41 PM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
7:45 AM
BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
02/05/2020
2:49 PM
MPM BIOVENTURES V, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
01/28/2020
8:57 AM
Rhythm Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/10/2020
7:46 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
3:00 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2019
3:02 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:25 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:13 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
7:05 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2019
1:40 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
3:22 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.